13F reference period
n/a
Security Snapshot
Frazier Life Sciences Acquisition Corp. II - Class A Ordinary Shares, par value $0.0001 per share Institutional Ownership
CUSIP: G37103101
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
n/a
Price
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 7,777,778
Filing notes and source
Key facts
- G37103101 - Frazier Life Sciences Acquisition Corp. II - Class A Ordinary Shares, par value $0.0001 per share is tracked under CUSIP G37103101.
- 13F reference-period holder data is not available.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
G37103101
13F reference period
n/a
13F holders
13D/G owners
6
CIK / CUSIP context first
G37103101 full holder history
Frazier Life Sciences Acquisition Corp. II SEC filings
Frazier Life Sciences Acquisition Corp. II insider transactions
Broader feeds
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
G37103101
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Holdings II LLC | 20% | 1,983,749 | Frazier Life Sciences Holdings II LLC | 15 Oct 2026 | ||||
| Deep Track Capital, LP | 9% | 700,000 | Deep Track Capital, LP | 14 Oct 2026 | ||||
| RA CAPITAL MANAGEMENT, L.P. | 9% | 700,000 | RA Capital Management, L.P. | 15 Oct 2026 | ||||
| Venrock Healthcare Capital Partners III, L.P. | 9% | 700,000 | Venrock Healthcare Capital Partners III, L.P. | 15 Oct 2026 | ||||
| Coastlands Capital LP | 6.4% | 500,000 | Coastlands Capital LP | 15 Oct 2026 | ||||
| BIOTECHNOLOGY VALUE FUND L P | 6.4% | 500,000 | BVF PARTNERS L P/IL | 14 Oct 2026 |